심혈관 임플란트 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2029년에는 연평균 성장률(CAGR) 6.2%로 366억 9,000만 달러로 성장합니다. 예측 기간의 성장은 맞춤형 의료 접근법, 최소 침습적 시술에 대한 관심, 심혈관 연구 분야의 세계 협력, 예방적 개입을 강조하는 의료 정책, 환자 중심의 심혈관 치료 등에 기인합니다. 예측 기간의 주요 동향으로는 약제용출 스텐트의 발전, 차세대 심장 판막의 부상, 인공지능(AI) 통합 증가, 최소침습적 이식술에 대한 관심, 환자 맞춤형 임플란트, 무연성 인공심장판막의 개발 등이 있습니다.
심장질환의 유병률 증가는 향후 수년간 심혈관 임플란트 시장의 성장을 가속할 것으로 예상됩니다. 심장질환에는 관상동맥질환, 심부전, 부정맥, 판막증 등 심장과 혈관에 영향을 미치는 다양한 질환이 포함됩니다. 관상동맥질환, 심부전 등 심장질환 증가로 인해 스텐트, 심박조율기 등 심혈관 임플란트에 대한 수요가 증가하고 있습니다. 이러한 임플란트는 심부전 환자의 심장 기능과 순환을 돕고, 심장 리듬을 조절하고, 심장 활동을 모니터링하는 데 도움이 되기 때문입니다. 예를 들어 2024년 9월 영국에 기반을 둔 자선단체인 영국 심장재단(BHF)은 심장 및 순환기 질환에 대한 연구 자금 지원과 인식 제고에 중점을 두고 있으며, 2030년까지 약 760만 명이 심장 및 순환기 질환을 앓고 있으며, 2040년까지 이 수치는 100만 명 증가, 2040년까지는 200만 명 더 늘어날 것으로 예상했습니다. 까지 200만 명이 더 늘어날 수 있습니다. 따라서 심장질환의 유병률 증가는 심혈관 임플란트 시장을 촉진하고 있습니다.
고령화 인구 증가가 향후 심혈관 임플란트 시장의 성장을 촉진할 것으로 예상됩니다. 고령화는 인구에서 60세 이상 인구의 비율이 높아지는 인구 통계학적 변화를 반영합니다. 심혈관 임플란트는 노년층에 만연한 심혈관 질환의 관리 및 치료에 중요한 역할을 하며, 삶의 질 향상, 수명 연장 및 전반적인 건강 상태 개선에 기여하고 있으며, 2022년 10월 세계보건기구(WHO)에 따르면 2030년까지 전 세계 인구 6명 중 1명이 60세 이상이 될 것으로 예상됩니다. 이 수치는 2050년까지 21억 명에 달할 것으로 예상됩니다. 따라서 고령화 인구 증가는 심혈관 임플란트 시장의 성장을 가속하는 중요한 요인이 되고 있습니다.
목차
제1장 개요
제2장 시장의 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 코로나, 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계 심혈관 임플란트 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인, 억제요인)
- 최종 용도 산업의 분석
- 세계의 심혈관 임플란트 시장 : 성장률 분석
- 세계의 심혈관 임플란트 시장 실적 : 규모와 성장, 2019-2024
- 세계의 심혈관 임플란트 시장 예측 : 규모와 성장, 2024-2029, 2034F
- 세계의 심혈관 임플란트 TAM(Total Addressable Market)
제6장 시장 세분화
- 세계의 심혈관 임플란트 시장 : 제품별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 관상동맥 스텐트
- 이식형 제세동기(ICD)
- 심장판막
- 이식형 심장 페이스메이커
- 심장재동기 요법(CRT) 기기
- 말초 스텐트
- 세계의 심혈관 임플란트 시장 : 소재별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 금속 및 합금
- 폴리머
- 생물 재료
- 세계의 심혈관 임플란트 시장 : 용도별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 부정맥
- 급성 심근경색
- 심근허혈
- 기타 용도
- 세계의 심혈관 임플란트 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 병원
- 외래 수술 센터
- 심장 센터
- 세계의 심혈관 임플란트 시장, 관상동맥 스텐트의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 약제용출스텐트
- 베어메탈 스텐트
- 생체흡수성 스텐트
- 세계의 심혈관 임플란트 시장, 이식형 제세동기(ICD)의 유형별 서브 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 단강형 ICD
- 듀얼 챔버 ICD
- 양심실 ICD
- 세계의 심혈관 임플란트 시장, 심장판막의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 인공심장판막
- 생물학적 심장판막
- 경카테터 심장판막
- 세계의 심혈관 임플란트 시장, 이식형 심장 페이스메이커의 유형별 서브 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 단강 페이스메이커
- 듀얼 챔버 페이스메이커
- 양실 페이스메이커
- 세계의 심혈관 임플란트 시장, 심장재동기 요법(CRT) 기기의 서브 세분화(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
- CRT-P 디바이스(페이스메이커)
- CRT-D 디바이스(제세동기)
- 세계의 심혈관 임플란트 시장, 말초 스텐트의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 경동맥 스텐트
- 신장 동맥 스텐트
- 대퇴 동맥 스텐트
제7장 지역별·국가별 분석
- 세계의 심혈관 임플란트 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 세계의 심혈관 임플란트 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
- 심혈관 임플란트 시장 : 경쟁 구도
- 심혈관 임플란트 시장 : 기업 개요
- Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
- Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
- Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
- B. Braun Melsungen AG Overview, Products and Services, Strategy and Financial Analysis
- Edwards Lifesciences Corporation Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 대기업과 혁신적 기업
- W. L. Gore & Associates Inc.
- Cook Medical Incorporated
- Teleflex Incorporated
- Kyoto Medical Planning Co. Ltd.
- Abiomed Inc.
- Livanova PLC
- BIOTRONIK SE & Co. KG
- CryoLife Inc.
- Endologix Inc.
- Sorin Group
- Berlin Heart GmbH
- REVA Medical LLC.
- Syncardia Systems LLC
- Elixir Medical Corporation
- Fortimedix Surgical B.V.
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 합병과 인수
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
- 심혈관 임플란트 시장 2029 : 새로운 기회를 제공하는 국가
- 심혈관 임플란트 시장 2029 : 새로운 기회를 제공하는 부문
- 심혈관 임플란트 시장 2029 : 성장 전략
제36장 부록
KSA
Cardiovascular implants are medical devices surgically placed within the cardiovascular system to manage heart and vascular conditions. These devices are strategically inserted into the cardiovascular system to address conditions such as blocked arteries, irregular heart rhythms, or valve defects. The primary goal is to restore normal heart function and improve blood circulation.
The main types of products categorized under cardiovascular implants include coronary stents, implantable cardioverter defibrillators (ICD), heart valves, implanted cardiac pacemakers, cardiac resynchronization therapy (CRT) devices, and peripheral stents. A coronary stent is a small mesh tube inserted into a narrowed or blocked coronary artery to maintain its openness. Various materials, including metals and alloys, polymers, and biological materials, are used in the manufacturing of these implants. They find applications in treating conditions such as arrhythmias, acute myocardial infarction, myocardial ischemia, and others. These cardiovascular implants are utilized by various end-users, including hospitals, ambulatory surgical centers, and cardiac centers.
The cardiovascular implants market research report is one of a series of new reports from The Business Research Company that provides cardiovascular implants market statistics, including cardiovascular implants industry global market size, regional shares, competitors with a cardiovascular implants market share, detailed cardiovascular implants market segments, market trends and opportunities, and any further data you may need to thrive in the cardiovascular implants industry. This cardiovascular implants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The cardiovascular implants market size has grown strongly in recent years. It will grow from $26.8 billion in 2024 to $28.86 billion in 2025 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to aging population and cardiovascular risk, lifestyle-related cardiovascular risk factors, improvements in diagnostic technologies, growing awareness and screening programs, government initiatives for cardiovascular health.
The cardiovascular implants market size is expected to see strong growth in the next few years. It will grow to $36.69 billion in 2029 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to personalized medicine approaches, focus on minimally invasive procedures, global collaboration in cardiovascular research, healthcare policy emphasis on preventive interventions, patient-centric cardiovascular care. Major trends in the forecast period include advancements in drug-eluting stents, rise of next-generation heart valves, increasing integration of artificial intelligence (ai), focus on minimally invasive implantation techniques, personalized and patient-specific implants, development of leadless pacemakers.
The increasing prevalence of heart disorders is anticipated to drive the growth of the cardiovascular implants market in the coming years. Heart disorders encompass a range of medical conditions impacting the heart and blood vessels, such as coronary artery disease, heart failure, arrhythmias, and valve disorders. The demand for cardiovascular implants, including stents and pacemakers, is fueled by the rise in heart diseases like coronary artery disease and heart failure, as these implants help support heart function and circulation in heart failure patients, regulate heart rhythm, and monitor heart activity. For example, in September 2024, the British Heart Foundation (BHF), a UK-based charity focused on funding research and raising awareness about heart and circulatory diseases, reported that approximately 7.6 million individuals in the UK suffer from heart and circulatory diseases. By 2030, this number could increase by 1 million, and by 2040, it may grow by an additional 2 million. Therefore, the growing prevalence of heart disorders is boosting the cardiovascular implants market.
The increase in the aging population is expected to drive the growth of the cardiovascular implants market in the future. The aging population reflects a demographic shift characterized by a higher proportion of individuals aged 60 and above in a population. Cardiovascular implants play a crucial role in managing and treating cardiovascular diseases prevalent in older individuals, contributing to improved quality of life, increased longevity, and overall better health outcomes. According to the World Health Organization in October 2022, globally, 1 in 6 individuals is projected to be 60 or older by 2030, and this number is expected to reach 2.1 billion elderly people by 2050. Therefore, the rise in the aging population is a key factor driving the growth of the cardiovascular implants market.
Leading companies in the cardiovascular implants market are intensifying their focus on incorporating advanced technology, including artificial intelligence (AI), to optimize market profits and enhance precision in patient care and treatment. Advancements in cardiac monitoring technology involve continuous tracking and recording of a patient's heart activity for the diagnosis and management of heart conditions. In June 2023, BIOTRONIK SE & Co. KG launched the BIOMONITOR IV implantable cardiac monitor (ICM), the first globally, combining SmartECG technology with artificial intelligence. This innovation reduces false-positive detections by 86% while retaining 98% accuracy in detecting real episodes. BIOMONITOR IV offers additional benefits, including extended battery life and wireless connectivity for smooth data transmission and remote monitoring, reducing the need for frequent in-person clinic visits.
In April 2023, Abbott Laboratories acquired Cardiovascular Systems Inc. for $890 million, aiming to enhance its solutions for treating vascular disease. This strategic acquisition makes Cardiovascular Systems Inc. a wholly owned subsidiary of Abbott and strengthens Abbott's position in providing innovative solutions for peripheral and coronary vascular disease.
Major companies operating in the cardiovascular implants market report are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, B. Braun Melsungen AG, Edwards Lifesciences Corporation, W. L. Gore & Associates Inc., Cook Medical Incorporated, Teleflex Incorporated, Kyoto Medical Planning Co. Ltd., Abiomed Inc., Livanova PLC, BIOTRONIK SE & Co. KG, CryoLife Inc., Endologix Inc., Sorin Group, Berlin Heart GmbH, REVA Medical LLC., Syncardia Systems LLC, Elixir Medical Corporation, Fortimedix Surgical B.V., AMG International GmbH, CHF Solutions Inc., Proxy Biomedical Ltd., Calon Cardio-Technology Ltd., InspireMD Inc., Neovasc Inc., Shree Pacetronix Ltd., Vascutek Ltd (Terumo Corporation)
North America was the largest region in the cardiovascular implants market in 2024. The regions covered in the cardiovascular implants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the cardiovascular implants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The cardiovascular implants market consists of sales of aneurysm stent-grafts, cardiac resynchronization therapy (CRT) devices, ventricular assist devices, and peripheral vascular stents. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Cardiovascular Implants Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on cardiovascular implants market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for cardiovascular implants ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cardiovascular implants market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Product: Coronary Stent; Implantable Cardioverter Defibrillator (ICD); Heart Valve; Implanted Cardiac Pacemaker; Cardiac Resynchronization Therapy (CRT) Devices; Peripheral Stent
- 2) By Material: Metals and Alloys; Polymers; Biological Materials
- 3) By Application: Arrhythmias; Acute Myocardial Infarction; Myocardial Ischemia; Other Applications
- 4) By End-Users: Hospitals; Ambulatory Surgical Centers; Cardiac Centers
- Subsegments:
- 1) By Coronary Stent: Drug-Eluting Stents; Bare-Metal Stents; Bioabsorbable Stents
- 2) By Implantable Cardioverter Defibrillator (ICD): Single-Chamber ICD; Dual-Chamber ICD; Biventricular ICD
- 3) By Heart Valve: Mechanical Heart Valves; Biological Heart Valves; Transcatheter Heart Valves
- 4) By Implanted Cardiac Pacemaker: Single-Chamber Pacemaker; Dual-Chamber Pacemaker; Biventricular Pacemaker
- 5) By Cardiac Resynchronization Therapy (CRT) Devices: CRT-P Devices (Pacemakers); CRT-D Devices (Defibrillators)
- 6) By Peripheral Stent: Carotid Artery Stents; Renal Artery Stents; Femoral Artery Stents
- Companies Mentioned: Abbott Laboratories; Medtronic PLC; Boston Scientific Corporation; B. Braun Melsungen AG; Edwards Lifesciences Corporation
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Cardiovascular Implants Market Characteristics
3. Cardiovascular Implants Market Trends And Strategies
4. Cardiovascular Implants Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
5. Global Cardiovascular Implants Growth Analysis And Strategic Analysis Framework
- 5.1. Global Cardiovascular Implants PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Cardiovascular Implants Market Growth Rate Analysis
- 5.4. Global Cardiovascular Implants Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Cardiovascular Implants Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Cardiovascular Implants Total Addressable Market (TAM)
6. Cardiovascular Implants Market Segmentation
- 6.1. Global Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Coronary Stent
- Implantable Cardioverter Defibrillator (ICD)
- Heart Valve
- Implanted Cardiac Pacemaker
- Cardiac Resynchronization Therapy (CRT) Devices
- Peripheral Stent
- 6.2. Global Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Metals and Alloys
- Polymers
- Biological Materials
- 6.3. Global Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Arrhythmias
- Acute Myocardial Infarction
- Myocardial Ischemia
- Other Applications
- 6.4. Global Cardiovascular Implants Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals
- Ambulatory Surgical Centers
- Cardiac Centers
- 6.5. Global Cardiovascular Implants Market, Sub-Segmentation Of Coronary Stent, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Drug-Eluting Stents
- Bare-Metal Stents
- Bioabsorbable Stents
- 6.6. Global Cardiovascular Implants Market, Sub-Segmentation Of Implantable Cardioverter Defibrillator (ICD), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Single-Chamber ICD
- Dual-Chamber ICD
- Biventricular ICD
- 6.7. Global Cardiovascular Implants Market, Sub-Segmentation Of Heart Valve, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Mechanical Heart Valves
- Biological Heart Valves
- Transcatheter Heart Valves
- 6.8. Global Cardiovascular Implants Market, Sub-Segmentation Of Implanted Cardiac Pacemaker, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Single-Chamber Pacemaker
- Dual-Chamber Pacemaker
- Biventricular Pacemaker
- 6.9. Global Cardiovascular Implants Market, Sub-Segmentation Of Cardiac Resynchronization Therapy (CRT) Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- CRT-P Devices (Pacemakers)
- CRT-D Devices (Defibrillators)
- 6.10. Global Cardiovascular Implants Market, Sub-Segmentation Of Peripheral Stent, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Carotid Artery Stents
- Renal Artery Stents
- Femoral Artery Stents
7. Cardiovascular Implants Market Regional And Country Analysis
- 7.1. Global Cardiovascular Implants Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Cardiovascular Implants Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Cardiovascular Implants Market
- 8.1. Asia-Pacific Cardiovascular Implants Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Cardiovascular Implants Market
- 9.1. China Cardiovascular Implants Market Overview
- 9.2. China Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Cardiovascular Implants Market
- 10.1. India Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Cardiovascular Implants Market
- 11.1. Japan Cardiovascular Implants Market Overview
- 11.2. Japan Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Cardiovascular Implants Market
- 12.1. Australia Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Cardiovascular Implants Market
- 13.1. Indonesia Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Cardiovascular Implants Market
- 14.1. South Korea Cardiovascular Implants Market Overview
- 14.2. South Korea Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Cardiovascular Implants Market
- 15.1. Western Europe Cardiovascular Implants Market Overview
- 15.2. Western Europe Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Cardiovascular Implants Market
- 16.1. UK Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Cardiovascular Implants Market
- 17.1. Germany Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Cardiovascular Implants Market
- 18.1. France Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Cardiovascular Implants Market
- 19.1. Italy Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Cardiovascular Implants Market
- 20.1. Spain Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Cardiovascular Implants Market
- 21.1. Eastern Europe Cardiovascular Implants Market Overview
- 21.2. Eastern Europe Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Cardiovascular Implants Market
- 22.1. Russia Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Cardiovascular Implants Market
- 23.1. North America Cardiovascular Implants Market Overview
- 23.2. North America Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Cardiovascular Implants Market
- 24.1. USA Cardiovascular Implants Market Overview
- 24.2. USA Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Cardiovascular Implants Market
- 25.1. Canada Cardiovascular Implants Market Overview
- 25.2. Canada Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Cardiovascular Implants Market
- 26.1. South America Cardiovascular Implants Market Overview
- 26.2. South America Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Cardiovascular Implants Market
- 27.1. Brazil Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Cardiovascular Implants Market
- 28.1. Middle East Cardiovascular Implants Market Overview
- 28.2. Middle East Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Cardiovascular Implants Market
- 29.1. Africa Cardiovascular Implants Market Overview
- 29.2. Africa Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Cardiovascular Implants Market Competitive Landscape And Company Profiles
- 30.1. Cardiovascular Implants Market Competitive Landscape
- 30.2. Cardiovascular Implants Market Company Profiles
- 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. B. Braun Melsungen AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Edwards Lifesciences Corporation Overview, Products and Services, Strategy and Financial Analysis
31. Cardiovascular Implants Market Other Major And Innovative Companies
- 31.1. W. L. Gore & Associates Inc.
- 31.2. Cook Medical Incorporated
- 31.3. Teleflex Incorporated
- 31.4. Kyoto Medical Planning Co. Ltd.
- 31.5. Abiomed Inc.
- 31.6. Livanova PLC
- 31.7. BIOTRONIK SE & Co. KG
- 31.8. CryoLife Inc.
- 31.9. Endologix Inc.
- 31.10. Sorin Group
- 31.11. Berlin Heart GmbH
- 31.12. REVA Medical LLC.
- 31.13. Syncardia Systems LLC
- 31.14. Elixir Medical Corporation
- 31.15. Fortimedix Surgical B.V.
32. Global Cardiovascular Implants Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Cardiovascular Implants Market
34. Recent Developments In The Cardiovascular Implants Market
35. Cardiovascular Implants Market High Potential Countries, Segments and Strategies
- 35.1 Cardiovascular Implants Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Cardiovascular Implants Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Cardiovascular Implants Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
